|
2025-06-02 |
2025-05-30 |
B
Purchase
|
Non-Executive Director
|
47,097
+37.0%
187.15
US$3,072,251
|
47,097
+37.0%
|
187.15
|
US$3,072,251
|
|
|
2024-12-26 |
2024-12-23 |
B
Purchase
|
Chief Medical Officer
Officer
|
56,045
-23.2%
424.62
US$1,790,198
|
56,045
-23.2%
|
424.62
|
US$1,790,198
|
|
|
2024-12-23 |
2024-12-23 |
B
Purchase
|
General Counsel
Officer
|
6,545
+41.1%
20.17
US$3,494,388
|
6,545
+41.1%
|
20.17
|
US$3,494,388
|
|
|
2024-12-23 |
2024-12-23 |
B
Purchase
|
Chief Financial Officer
Officer
|
10,250
+13.8%
0.83
US$8,483
|
10,250
+13.8%
|
0.83
|
US$8,483
|
|
|
2024-12-23 |
2024-12-23 |
B
Purchase
|
Chief Executive Officer
Executive Director
|
12,500
+33.4%
0.81
US$10,120
|
12,500
+33.4%
|
0.81
|
US$10,120
|
|
|
2024-09-11 |
2024-09-11 |
PrS
Proposed sale
|
Stockholder
Large shareholder
|
1,000,000
0.84
US$844,000
|
1,000,000
|
0.84
|
US$844,000
|
|
|
2024-07-26 |
2024-07-26 |
S
Sale
|
Large shareholder
|
23,478
-0.5%
1.31
US$30,787
|
23,478
-0.5%
|
1.31
|
US$30,787
|
|
|
2024-07-26 |
2024-07-25 |
S
Sale
|
Large shareholder
|
51,522
-1.2%
1.33
US$68,339
|
51,522
-1.2%
|
1.33
|
US$68,339
|
|
|
2024-07-25 |
2024-07-25 |
PrS
Proposed sale
|
10% Stockholder
Large shareholder
|
75,000
1.35
US$101,250
|
75,000
|
1.35
|
US$101,250
|
|
|
2024-05-14 |
2024-05-10 |
S
Sale
|
Large shareholder
|
658,809
-12.9%
1.22
US$802,495
|
658,809
-12.9%
|
1.22
|
US$802,495
|
|
|
2024-05-10 |
2024-05-10 |
PrS
Proposed sale
|
10% Stockholder
Large shareholder
|
658,809
1.50
US$988,214
|
658,809
|
1.50
|
US$988,214
|
|
|
2024-02-13 |
2024-02-09 |
S
Sale
|
Large shareholder
|
658,809
-11.5%
1.50
US$988,411
|
658,809
-11.5%
|
1.50
|
US$988,411
|
|
|
2024-02-09 |
2024-02-09 |
PrS
Proposed sale
|
10% Stockholder
Large shareholder
|
658,809
1.85
US$1,218,797
|
658,809
|
1.85
|
US$1,218,797
|
|
|
2023-11-24 |
2023-11-22 |
B
Purchase
|
Chief Accounting Officer
Officer
|
5,000
+76.9%
1.04
US$5,175
|
5,000
+76.9%
|
1.04
|
US$5,175
|
|
|
2023-11-24 |
2023-11-21 |
B
Purchase
|
Chief Accounting Officer
Officer
|
5,000
+333.3%
0.99
US$4,950
|
5,000
+333.3%
|
0.99
|
US$4,950
|
|
|
2023-08-11 |
2023-08-09 |
B
Purchase
|
Large shareholder
|
2,469,135
+76.2%
2.03
US$4,999,998
|
2,469,135
+76.2%
|
2.03
|
US$4,999,998
|
|
|
2023-08-10 |
2023-08-09 |
B
Purchase
|
Large shareholder
|
3,157,894
+inf%
1.90
US$5,999,999
|
3,157,894
+inf%
|
1.90
|
US$5,999,999
|
|
|
2023-03-20 |
2023-03-17 |
B
Purchase
|
Chief Financial Officer
Officer
|
25,000
+inf%
2.32
US$58,018
|
25,000
+inf%
|
2.32
|
US$58,018
|
|
|
2021-11-12 |
2021-11-09 |
B
Purchase
|
Non-Executive Director
|
75,000
+4.4%
14.00
US$1,050,000
|
75,000
+4.4%
|
14.00
|
US$1,050,000
|
|
|
2021-11-12 |
2021-11-09 |
B
Purchase
|
Non-Executive Director
|
650,000
+27.5%
14.00
US$9,100,000
|
650,000
+27.5%
|
14.00
|
US$9,100,000
|
|
|
2021-11-12 |
2021-11-09 |
B
Purchase
|
Large shareholder
|
2,142,857
+54.9%
14.00
US$29,999,998
|
2,142,857
+54.9%
|
14.00
|
US$29,999,998
|
|
|
2021-11-12 |
2021-11-09 |
B
Purchase
|
Large shareholder
|
325,000
+13.7%
14.00
US$4,550,000
|
325,000
+13.7%
|
14.00
|
US$4,550,000
|
|
|
2021-11-12 |
2021-11-09 |
B
Purchase
|
Large shareholder
|
650,000
+27.5%
14.00
US$9,100,000
|
650,000
+27.5%
|
14.00
|
US$9,100,000
|
|
|
2021-11-12 |
2021-11-09 |
B
Purchase
|
Non-Executive Director
|
162,500
+60.6%
14.00
US$2,275,000
|
162,500
+60.6%
|
14.00
|
US$2,275,000
|
|
|
2021-11-12 |
2021-11-09 |
B
Purchase
|
Non-Executive Director
|
162,500
+20.4%
14.00
US$2,275,000
|
162,500
+20.4%
|
14.00
|
US$2,275,000
|
|
|
2021-11-10 |
2021-11-09 |
B
Purchase
|
Large shareholder
|
325,000
+11.0%
14.00
US$4,550,000
|
325,000
+11.0%
|
14.00
|
US$4,550,000
|
|